BHC · Bausch Health Companies Inc.

$6.89 -0.04 (-0.58%) At close · Aug 19

Market Cap

$2.59B

373.99M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas Appio	Chief Executive Officer	$1,236,000	$250,000	$13,032,562	—	$2,336,000	$22,764	$16,877,326
Aimee J. Lenar	Executive Vice President, US Pharma	$650,000	—	$1,958,861	—	$628,880	$26,750	$3,264,491

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas Appio	Chief Executive Officer	$1,226,308	—	$13,141,574	—	$1,854,000	$17,251	$16,239,133
Jean-Jaques Charhon	Executive Vice President and Chief Financial Officer	$255,769	$300,000	$3,526,288	—	$185,030	—	$4,267,087
Jean-Jacques Charhon	Executive Vice President, Chief Financial Officer	$255,769	$300,000	$3,526,288	—	$185,030	—	$4,267,087
Seana Carson	Executive Vice President and General Counsel	$579,670	—	$2,950,720	—	$433,150	$8,939	$3,972,479
Aimee J. Lenar	Executive Vice President, US Pharma	$300,000	$400,000	$1,056,657	—	$227,530	$2,250	$1,986,437

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas Appio	Chief Executive Officer	$1,169,231	—	$13,133,812	—	$1,545,000	$30,535	$15,878,578
Seana Carson	Executive Vice President and General Counsel	$527,624	—	$1,885,259	$399,910	$333,341	$11,683	$3,157,817
John Barresi	Senior Vice President, Controller, Chief Accounting Officer and former interim Chief Financial Officer	$465,577	$50,000	$500,773	$106,224	$266,377	$14,850	$1,403,801

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas Appio	Chief Executive Officer	$1,000,000	—	$4,690,507	$3,748,138	$798,000	$2,934,816	$13,171,461
Tom Vadaketh	Executive Vice President and Chief Financial Officer	$600,000	$500,000	$5,083,699	$2,574,803	$239,472	$13,725	$9,011,699
Robert A. Spurr	Former President US Pharmaceutical Business	$336,538	—	$861,105	$874,563	—	$2,230,891	$4,303,097
Seana Carson	Executive Vice President and General Counsel	$506,590	—	$2,667,605	$824,586	$202,190	$11,724	$4,212,695

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Papa	Former Chief Executive Officer	$1,600,000	—	$16,561,105	$2,250,054	$2,448,000	$29,978	$22,889,137
Thomas Appio	Chief Executive Officer	$854,135	—	$6,752,818	$540,009	$1,202,000	$839,084	$10,188,046
Paul Herendeen	Former Executive Vice President and Chief Financial Officer	$707,692	—	$4,109,488	$1,050,034	$1,010,000	$21,635	$6,898,849
Christina M. Ackermann	Former Executive Vice President and General Counsel and Head of Commercial Operations	$750,000	—	$2,348,225	$600,033	$862,000	$14,330	$4,574,588
Sam Eldessouky	Former Executive Vice President and Chief Financial Officer	$620,385	—	$1,778,793	$1,187,756	$731,950	$13,340	$4,332,224
Robert A. Spurr	President, U.S. Pharma Business	$636,154	—	$1,768,210	$625,010	$821,200	$18,050	$3,868,624

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Papa	Former Chief Executive Officer	$1,526,539	—	$8,127,907	$2,251,352	$2,160,000	$53,563	$14,119,361
Paul Herendeen	Former Executive Vice President and Chief Financial Officer	$1,000,000	—	$2,815,424	$1,050,667	$1,080,000	$20,012	$5,966,103
Thomas Appio	Chief Executive Officer	$775,000	—	$1,131,025	$540,362	$558,000	$824,000	$3,828,387
William D. Humphries	Former President,	$750,000	—	$785,420	$375,263	$540,000	$1,364,750	$3,815,433
Christina M. Ackermann	Former Executive Vice President and General Counsel and Head of Commercial Operations	$743,654	—	$1,692,387	$540,362	$540,000	$24,625	$3,541,028
Sam Eldessouky	Former Executive Vice President and Chief Financial Officer	$500,000	—	$392,709	$187,631	$225,000	$12,825	$1,318,165

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Papa	Chief Executive Officer	$1,500,000	—	$10,286,634	$1,999,998	$3,240,000	$115,014	$17,141,646
Paul Herendeen	Former Executive Vice President and Chief Financial Officer	$1,000,000	—	$3,175,712	$1,050,049	$1,728,000	$23,600	$6,977,361
Thomas Appio	President & Co-Head Bausch + Lomb/International	$768,942	—	$1,343,982	$525,050	$892,800	$427,227	$3,958,001
William D. Humphries	Former President,	$750,000	—	$1,613,943	$375,048	$864,000	$12,600	$3,615,591
Christina M. Ackermann	Executive Vice President, General Counsel and Head of Commercial Operations	$690,308	—	$1,343,982	$525,050	$806,400	$14,192	$3,379,932

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Papa	Chief Executive Officer	$1,500,000	—	$7,344,927	$1,999,715	$3,802,500	$93,908	$14,741,050
Paul Herendeen	Executive Vice President and Chief Financial Officer	$1,000,000	—	$2,310,572	$1,049,860	$2,028,000	$12,375	$6,400,807
Thomas Appio	President & Co-Head Bausch + Lomb/International	$730,385	—	$1,365,256	$389,954	$918,000	$983,007	$4,386,602
Christina M. Ackermann	Executive Vice President, General Counsel and Head of Commercial Operations	$647,539	—	$723,176	$359,964	$892,320	$763,908	$3,386,907
William D. Humphries	President,	$750,000	—	—	—	$612,000	$12,375	$1,374,375
Ortho Dermatologics	—	$750,000	—	—	—	$612,000	$12,375	$1,374,375

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ortho Dermatologics	—	$750,000	$3,000,000	$3,225,011	$899,995	$551,250	$7,950	$8,434,206
Joseph Papa	Chief Executive Officer	$1,500,000	—	—	—	$2,981,250	$413,858	$4,895,108
Thomas Appio	President & Co-Head Bausch + Lomb/International	$650,000	—	$1,133,771	$180,012	$669,500	$796,003	$3,429,286
Christina M. Ackermann	Executive Vice President and General Counsel	$600,000	—	$906,030	$360,006	$636,000	$293,116	$2,795,152
Paul Herendeen	Executive Vice President and Chief Financial Officer	$1,000,000	—	—	—	$1,590,000	$7,950	$2,597,950

Executive changes

Person	Role	Change	Effective	Filed
Michael Goettler	Board of Directors	Resigned	2026-06-30	2026-07-01
Steven D. Miller	board of directors	Resigned	2025-08-14	2025-08-15
Brett M. Icahn	board of directors	Resigned	2025-08-14	2025-08-15
Sandra Leung	Board of Directors	Appointed	2025-07-22	2025-07-24
Michael Goettler	Board of Directors	Appointed	2025-07-22	2025-07-24
Steven Lee	Senior Vice President, Controller and Chief Accounting Officer	Appointed	2025-07-14	2025-07-10
John S. Barresi	Senior Vice President, Controller and Chief Accounting Officer	Resigned	2025-06-02	2025-05-15
Jean-Jacques Charhon	Executive Vice President and Chief Financial Officer	Appointed	2024-08-19	2024-07-19
Thomas W. Ross, Sr.	members of the Board	Retired	—	2024-02-01
Russel C. Robertson	members of the Board	Retired	—	2024-02-01
Tom Vadaketh	Executive Vice President, Chief Financial Officer	Resigned	2023-10-13	2023-09-18
John A. Paulson	Chairperson of the Board	Appointed	2022-06-23	2022-06-24
John A. Paulson	the Board	Appointed	2022-06-23	2022-06-24
Joseph C. Papa	Board of Directors	Resigned	2022-06-23	2022-06-24
Russel C. Robertson	Director	Appointed	2022-06-21	2022-06-24
Thomas W. Ross, Sr.	Director	Appointed	2022-06-21	2022-06-24
Richard C. Mulligan	Director	Appointed	2022-06-21	2022-06-24
Joseph C. Papa	Director	Appointed	2022-06-21	2022-06-24
Robert N. Power	Director	Appointed	2022-06-21	2022-06-24
Steven D. Miller	Director	Appointed	2022-06-21	2022-06-24
Sarah B. Kavanagh	Director	Appointed	2022-06-21	2022-06-24
Argeris (Jerry) N. Karabelas	Director	Appointed	2022-06-21	2022-06-24
Brett Icahn	Director	Appointed	2022-06-21	2022-06-24
Richard U. De Schutter	Director	Appointed	2022-06-21	2022-06-24
Thomas J. Appio	Director	Appointed	2022-06-21	2022-06-24

Key facts CIK 885590 CUSIP 071734107 13F (30d) 206 filings 205 filers Visit website Investor relations